Bladder Cancer Clinical Trial
Bladder Bank (a Prospective Banking Study)
Summary
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Full Description
PRIMARY OBJECTIVE:
I. To establish a biobank of samples (blood and urine) to support the development of non-invasive tests for early detection of bladder cancer.
OUTLINE: This is an observational study.
Patients undergo blood and urine sample collection and have their medical records reviewed while on study.
Eligibility Criteria
Inclusion Criteria:
Age > 18 years
Patient has undergone office-based evaluation for hematuria (computed tomography [CT], ultrasound, cystoscopy)
Exclusion Criteria:
Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)
Patient has recurrent muscle invasive bladder cancer
Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection
Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection
Patient has had any prior radiation therapy to the target lesion prior to current collection
Patient has had a biopsy to the target organ and/or lesion within 3 days before collection
Patient has undergone cystectomy
Patient has transurethral instrumentation (placement of urinary catheter) within 7 days prior to urine collection
Patient has had a urinary tract infection within 14 days prior to urine collection
Patient has chronic indwelling urinary catheter
Patient has prior diagnosis of bladder cancer for which prior resection of tumor was performed
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Rochester Minnesota, 55905, United States More Info
Principal Investigator
How clear is this clinincal trial information?